Race and ethnicity representation in clinical trials: Findings from a literature review of Phase I oncology trials

Authors

D Ross Camidge, University of Colorado
Haeseong Park, Washington University School of Medicine in St. Louis
Karen E Smoyer, Envision Pharma Group
Ira Jacobs, Pfizer
Lauren J Lee, Pfizer
Zemfira Askerova, Pfizer
Justin McGinnis, Pfizer
Yousef Zakharia, University of Iowa

Journal

Future Oncology

Publication Date

8-1-2021

Volume

17

Issue

24

First Page

3271

Last Page

3280

Document Type

Open Access Publication

DOI

10.2217/fon-2020-1262

Rights and Permissions

Camidge DR, Park H, Smoyer KE, Jacobs I, Lee LJ, Askerova Z, McGinnis J, Zakharia Y. Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials. Future Oncol. 2021 Aug;17(24):3271-3280. doi: 10.2217/fon-2020-1262. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. For full bibliographic citation, please refer to the version available at www.futuremedicine.com.

Recommended Citation

Camidge, D Ross; Park, Haeseong; Smoyer, Karen E; Jacobs, Ira; Lee, Lauren J; Askerova, Zemfira; McGinnis, Justin; and Zakharia, Yousef, "Race and ethnicity representation in clinical trials: Findings from a literature review of Phase I oncology trials." Future Oncology. 17, 24. 3271 - 3280. (2021).
https://digitalcommons.wustl.edu/oa_4/420